Top Stories
L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM
Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM
Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM

Dr. Reddy’s API plant completes U.S. FDA inspection in Srikakulam facility
Dr Reddy's Laboratories Ltd. said in the regulatory filing on Wednesday that the US FDA (Food and Drug Administration) has successfully completed both the pre-approval inspection and a routine inspection of good manufacturing practices at the API manufacturing facility in Srikakulam, Andhra Pradesh, with no observations.
The facility for active pharmaceutical ingredients (APIs) was examined between July 10 and July 19, 2023.
According to the company's filing with the exchange, it closed with no observations and was classified as No Action Indicated (NAI).
Reacting to this news, the share price of the company gained by Rs 148.6 or 2.8% at Rs 5,370.2 apiece on BSE, surpassing an earlier 52-week high of Rs 5,272.4 apiece hit on July 7.
Source: Media Reports
Related News

L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM

NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr
4 mins read. August 2, 2024 at 12:33 PM
Download app
Access BlinkX
everywhere
across device
